These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2808834)

  • 1. Topical corticosteroid compounding: effects on physicochemical stability and skin penetration rate.
    Krochmal L; Wang JC; Patel B; Rodgers J
    J Am Acad Dermatol; 1989 Nov; 21(5 Pt 1):979-84. PubMed ID: 2808834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of topical therapy of psoriasis.
    Wohlrab W; Wozniak KD; Taube KM
    Acta Univ Carol Med (Praha); 1986; 32(3-4):249-54. PubMed ID: 3434484
    [No Abstract]   [Full Text] [Related]  

  • 3. Transdermal iontophoretic delivery of triamcinolone acetonide: a preliminary study in hairless rats.
    Shigeki S; Murakami T; Kiyonaka G; Yata N; Ikuta Y
    Scand J Plast Reconstr Surg Hand Surg; 1996 Sep; 30(3):177-81. PubMed ID: 8885011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of concentration and degree of saturation of topical fluocinonide formulations on in vitro membrane transport and in vivo availability on human skin.
    Schwarb FP; Imanidis G; Smith EW; Haigh JM; Surber C
    Pharm Res; 1999 Jun; 16(6):909-15. PubMed ID: 10397613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of selected variables on fabrication of Triamcinolone acetonide loaded solid lipid nanoparticles for topical treatment of dermal disorders.
    Pradhan M; Singh D; Singh MR
    Artif Cells Nanomed Biotechnol; 2016; 44(1):392-400. PubMed ID: 25229831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing effect of pyrrolidone derivatives on transdermal penetration of 5-fluorouracil, triamcinolone acetonide, indomethacin, and flurbiprofen.
    Sasaki H; Kojima M; Mori Y; Nakamura J; Shibasaki J
    J Pharm Sci; 1991 Jun; 80(6):533-8. PubMed ID: 1941542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No effect of albumin on the dermal absorption rate of hydrocortisone 21-butyrate, permethrin or diflunisal in the isolated, single-pass perfused rabbit ear.
    Bast GE; Kampffmeyer HG
    Skin Pharmacol; 1996; 9(5):327-33. PubMed ID: 8990508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Simultaneous determination of urea and hydrocortisone penetration into human skin].
    Wohlrab W
    Dermatol Monatsschr; 1990; 176(2-3):139-43. PubMed ID: 2365109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cosmetic and physicochemical properties of six topical corticosteroid creams.
    Hadzija BW; Ambrose WW
    Cutis; 1996 Feb; 57(2 Suppl):13-8. PubMed ID: 8646864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of hydrocolloid patch composition on the bioavailability of triamcinolone acetonide in humans.
    Martin GP; Ladenheim D; Marriott C; Hollingsbee DA; Brown MB
    Drug Dev Ind Pharm; 2000 Jan; 26(1):35-43. PubMed ID: 10677808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the effect of pH on the lipoidal route of penetration across stratum corneum.
    Sznitowska M; Janicki S; Baczek A
    J Control Release; 2001 Oct; 76(3):327-35. PubMed ID: 11578746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous corticosteroid absorption correlated to partition coefficient.
    Katz M; Shaikh ZI
    J Pharm Sci; 1965 Apr; 54(4):591-4. PubMed ID: 5842347
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of urea on the penetration kinetics of topically applied corticosteroids.
    Wohlrab W
    Acta Derm Venereol; 1984; 64(3):233-8. PubMed ID: 6204485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of surface preparation on the penetration of hydrocortisone through canine skin.
    Ahlstrom LA; Cross SE; Morton JM; Mills PC
    Vet J; 2009 Apr; 180(1):48-54. PubMed ID: 18294885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stratum corneum absorption kinetics of 2 potent topical corticosteroid formulations: a pilot study.
    Draelos ZD
    Cutis; 2015 Aug; 96(2):135-41. PubMed ID: 26367752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evaluation of a novel corticosteroid formulation, fluocinonide in "FAPG" base, in the blanching test.
    Coldman MF; Lockerbie L; Laws EA
    Br J Dermatol; 1971 Dec; 85(6):573-6. PubMed ID: 4947552
    [No Abstract]   [Full Text] [Related]  

  • 17. Vehicle design for a new topical steroid, fluocinonide.
    Ostrenga J; Haleblian J; Poulsen B; Ferrell B; Mueller N; Shastri S
    J Invest Dermatol; 1971 May; 56(5):392-9. PubMed ID: 5556528
    [No Abstract]   [Full Text] [Related]  

  • 18. Circadian plasma cortisol levels during topical use of desoximetasone and triamcinolone acetonide in man.
    Hartmann F; Proppe A; Proppe D
    Eur J Clin Pharmacol; 1980 May; 17(5):363-9. PubMed ID: 6893435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional differences in the in vitro penetration of hydrocortisone through equine skin.
    Mills PC; Cross SE
    J Vet Pharmacol Ther; 2006 Feb; 29(1):25-30. PubMed ID: 16420298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantifying systemic absorption of topical hydrocortisone in erythroderma.
    Aalto-Korte K; Turpeinen M
    Br J Dermatol; 1995 Sep; 133(3):403-8. PubMed ID: 8546995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.